# Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery

> **NCT06280092** · EARLY_PHASE1 · RECRUITING · sponsor: **Sanjeet S. Grewal** · enrollment: 5 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** AMSCs

## Key facts

- **NCT ID:** NCT06280092
- **Lead sponsor:** Sanjeet S. Grewal
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-23
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06280092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06280092, "Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06280092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*